Takeda

Are Takeda's 900 Contrave reps worth it? Maybe not, analyst says
Fierce Pharma Marketing
Mon, 11/9/15 - 03:38 pm
Takeda
Contrave
drug reps
Orexigen
The top 10 biopharma pipeline disasters of 2015
Fierce Biotech
Fri, 10/30/15 - 09:55 am
Eli Lilly
GSK
AstraZeneca
Shire
Celladon
Takeda
Merck
Roche
Verastem
evacetrapib
Breo Ellipta
brodalumab
selumetinib
SHP625
Mydicar
Alisertib
suggammadex
sembragiline
Defactinib
Takeda keeps Actos settlement ball rolling with two new resolutions
Fierce Pharma
Mon, 10/12/15 - 11:44 am
Takeda
Actos
diabetes
Contrave script growth snags, despite Takeda's 900-strong salesforce
Fierce Pharma Marketing
Tue, 09/29/15 - 09:16 am
Contrave
Takeda
Orexigen
obesity
Takeda gets enough takers to complete $2.3B Actos settlement
Fierce Pharma
Mon, 09/14/15 - 05:45 pm
Takeda
Actos
diabetes
Here's What Caused Orexigen Therapeutics to Slim Down in August
Motley Fool
Mon, 09/7/15 - 11:44 am
Orexigen Therapeutics
Takeda
Contrave
FDA warns of severe joint pain risk with DPP-4 diabetes drugs
Yahoo/Reuters
Fri, 08/28/15 - 05:52 pm
FDA
diabetes
joint pain
DPP-4 inhibitor
Merck
Januvia
Onglyza
AstraZeneca
Takeda
Boehringer Ingelheim
Takeda Actos settlement seems shaky as plaintiffs give it the sniff test
Fierce Pharma
Fri, 08/14/15 - 11:17 am
Takeda
Actos
diabetes
bladder cancer
Takeda revamps commercial org to synch with R&D
Medical Marketing and Media
Thu, 06/18/15 - 06:11 pm
R&D
Takeda
AdverseEvents: Diabetes drug analysis flags heart failure, pancreatitis reports
Fierce Pharma
Tue, 06/16/15 - 12:08 pm
diabetes
side effects
heart failure
pancreatitis
Nesina
Takeda
Onglyza
AstraZeneca
Farixga
Byetta
Victoza
Januvia
Merck
Novo Nordisk
Nobel Laureate Allies With Takeda in Hunt for Blockbuster Drugs
Bloomberg
Tue, 06/16/15 - 09:13 am
Takeda
R&D
Some heartburn drugs linked to increased risk of heart attack
Medical Marketing and Media
Fri, 06/12/15 - 10:47 am
heartburn
heart attack
Nexium
Prilosec
Prevacid
AstraZeneca
Takeda
P&G
proton pump inhibitors
Brutal honesty in drug marketing? For obesity meds, it's key to avoiding the 'magic pill' trap
Fierce Pharma Marketing
Mon, 06/8/15 - 12:13 pm
obesity
Takeda
Contrave
Orexigen
Vivus
Qsymia
Eisai
Belviq
Arena Pharmaceuticals
Orexigen, Takeda take Actavis to court over obesity med Contrave generic
BioPharma Dive
Mon, 06/8/15 - 11:03 am
Orexigen
Takeda
Actavis
obesity
generics
Contrave
Orexigen and Takeda File Lawsuit Against Actavis for Infringement of Contrave® Patents
Yahoo
Fri, 06/5/15 - 09:13 am
Orexigen
Takeda
Actavis
patents
Contrave
Are Problems at Orexigen Still Just Getting Started?
24/7 Wall St
Thu, 05/14/15 - 09:54 am
Orexigen
Contrave
Takeda
Orexigen and Takeda Feud Over Cost of a Controversial Diet Drug Trial
WSJ Pharmalot
Wed, 05/13/15 - 05:01 pm
Orexigen
Takeda
Contrave
clinical trials
Takeda inks a $270M stem cell deal with Kyoto University
Fierce Biotech
Fri, 04/17/15 - 12:38 pm
Takeda
Japan
stem cells
R&D
Takeda names U.S. head, currently its sole female executive
Fierce Pharma Asia
Tue, 04/14/15 - 12:46 pm
Takeda
Ramona Sequeira
Safety scare with AstraZeneca's diabetes drug could shake up the DPP-4 field
Fierce Biotech
Fri, 04/10/15 - 03:54 pm
AstraZeneca
Onglyza
diabetes
DPP-4 inhibitor
Takeda
Merck
Nesina
Januvia

Pages